Recruitment

Recruitment Status
Recruiting

Inclusion Criteria

Scheduled colonoscopy for diagnostic purposes
Age ≥ 18 and ≤ 85 years
Chronic kidney disease ≤ stage III (KDOQI), i.e., estimated glomerular filtration rate (MDRD) < 60 ml/min/m² or need of dialysis therapy 27
...
Scheduled colonoscopy for diagnostic purposes
Age ≥ 18 and ≤ 85 years
Chronic kidney disease ≤ stage III (KDOQI), i.e., estimated glomerular filtration rate (MDRD) < 60 ml/min/m² or need of dialysis therapy 27
Written informed consent

Exclusion Criteria

Recipient of a renal or other solid organ transplant
Exposure to antibiotics or drug therapy with a known influence on intestinal transporters (e.g., P-gp) or enzymes during 2 weeks before colonoscopy
History of gastro-intestinal disease (e.g., inflammatory bowel disease)
...
Recipient of a renal or other solid organ transplant
Exposure to antibiotics or drug therapy with a known influence on intestinal transporters (e.g., P-gp) or enzymes during 2 weeks before colonoscopy
History of gastro-intestinal disease (e.g., inflammatory bowel disease)
History of colon surgery

Summary

Conditions
Chronic Kidney Disease
Type
Observational
Design
  • Observational Model: Cohort
  • Time Perspective: Prospective

Participation Requirements

Age
Between 18 years and 85 years
Gender
Both males and females

Inclusion Criteria

Scheduled colonoscopy for diagnostic purposes
Age ≥ 18 and ≤ 85 years
Chronic kidney disease ≤ stage III (KDOQI), i.e., estimated glomerular filtration rate (MDRD) < 60 ml/min/m² or need of dialysis therapy 27
...
Scheduled colonoscopy for diagnostic purposes
Age ≥ 18 and ≤ 85 years
Chronic kidney disease ≤ stage III (KDOQI), i.e., estimated glomerular filtration rate (MDRD) < 60 ml/min/m² or need of dialysis therapy 27
Written informed consent

Exclusion Criteria

Recipient of a renal or other solid organ transplant
Exposure to antibiotics or drug therapy with a known influence on intestinal transporters (e.g., P-gp) or enzymes during 2 weeks before colonoscopy
History of gastro-intestinal disease (e.g., inflammatory bowel disease)
...
Recipient of a renal or other solid organ transplant
Exposure to antibiotics or drug therapy with a known influence on intestinal transporters (e.g., P-gp) or enzymes during 2 weeks before colonoscopy
History of gastro-intestinal disease (e.g., inflammatory bowel disease)
History of colon surgery

Tracking Information

NCT #
NCT01752738
Collaborators
Not Provided
Investigators
  • Principal Investigator: Bjorn Meijers, MD, PhD UZ Leuven Principal Investigator: Sander Dejongh KU Leuven
  • Bjorn Meijers, MD, PhD UZ Leuven Principal Investigator: Sander Dejongh KU Leuven
About Us
Innovation
Privacy
Terms
Copyright
Get Well Soon © Copyright 2024